Skip To Main Content
Céline SC Hardy on Muck Rack

Céline SC Hardy

As seen in: Wiley Online Library, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Céline SC

Contact Céline SC, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Herpes simplex virus‐1 infection alters microtubule‐associated protein Tau splicing and promotes Tau pathology in neural models of Alzheimer's disease - Ijezie - Brain Pathology - Wiley Online Library

|
By Emmanuel C. Ijezie, Michael Miller, Céline SC Hardy, Ava Jarvis
| Wiley Online Library Verified
1 INTRODUCTION Alzheimer's disease (AD) is a neurological disorder that is characterized by progressive neurodegeneration and accumulation of amyloid-ß (Aβ) plaques and aggregated Tau proteins [1]. AD is currently the leading cause of dementia in the world. The economic impact of AD progression on the United States healthcare system is projected to be in excess of $360 billion in 2024, and this number is expected to continue rising [2].
Open in Who Shared Issue with article?

HSV-1 Infection Alters MAPT Splicing and Promotes Tau Pathology in Neural Models of Alzheimer's Disease

|
By Emmanuel C. Ijezie, Michael Miller, Céline SC Hardy, Ava Jarvis
| BioRxiv
Abstract INTRODUCTION: Herpes simplex virus 1 (HSV-1) infection alters critical markers of Alzheimer's Disease (AD) in neurons. One key marker of AD is the hyperphosphorylation of Tau, accompanied by altered levels of Tau isoforms.
Open in Who Shared Issue with article?

Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer

|
By Chelsea Jackson, Lina Chen, Kevin Ren, Céline SC Hardy
| Wiley Online Library Verified
Abstract Intrinsic molecular subtypes may explain marked variation between bladder cancer patients in prognosis and response to therapy. Complex testing algorithms and little attention to more prevalent, early-stage (non-muscle invasive) bladder cancers (NMIBCs) have hindered implementation of subtyping in clinical practice.
Open in Who Shared Issue with article?
See all 3 articles